Glucocorticoid Programming in Very Preterm Birth

Horm Res Paediatr. 2016;85(4):221-31. doi: 10.1159/000443734. Epub 2016 Mar 5.

Abstract

Very preterm (i.e., <32 weeks of gestation) infants admitted to the neonatal intensive care unit are compromised in their abilities to respond adequately to common threats like hemodynamic changes and reduced energy supplies, which is partly attributable to adrenocortical insufficiency. Conversely, later in life, these infants show features of increased glucocorticoid bioactivity, such as abdominal fat distribution, raised blood pressure, insulin resistance and diabetes mellitus type 2. It has been suggested that the very preterm newborn responds to the adverse postnatal environment with a sustained elevation in hypothalamus-pituitary-adrenal axis activity that persists beyond infancy. This has implications for subsequent growth, body composition, metabolism, neurodevelopment and, ultimately, long-term disease risk. The mechanisms underpinning these associations are not fully elucidated yet. This review gives a brief summary of studies that investigated adrenocortical function in very preterm newborns and how the axis changes with age, as a possible explanation for the association between prematurity and long-term outcome.

Publication types

  • Review

MeSH terms

  • Blood Pressure*
  • Female
  • Glucocorticoids / metabolism*
  • Humans
  • Hypothalamo-Hypophyseal System* / metabolism
  • Hypothalamo-Hypophyseal System* / physiopathology
  • Infant, Extremely Premature
  • Infant, Newborn
  • Insulin Resistance*
  • Male
  • Pituitary-Adrenal System* / physiopathology

Substances

  • Glucocorticoids